AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (611.5 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review Article | Open Access

Comparison of intramedullary transplantation of olfactory ensheathing cell for patients with chronic complete spinal cord injury worldwide

Lin Chen1Yuqi Zhang2Xijing He3Saberi Hooshang4
Department of Neurorestoratology, Yuquan Hospital, Tsinghua University, Beijing, China
Department of Neurosurgery, Yuquan Hospital, Tsinghua University, Beijing, China
Department of Orthopaedics, Second Affiliated Hospital of Xi'an Jiaotong University, Xi’an, China
Brain and Spinal cord Injury Research Center (BASIR), Neuroscience Institute, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
Show Author Information

Abstract

Objectives:

Traumatic spinal cord injury (tSCI) remains a major clinical challenge. Cell transplantation brings a glimmer of light, among them olfactory ensheathing cells (OECs) have shown some neurorestorative effect. Due to the results of each group lack basic consistency, many technical details are believed to affect the overall outcome. We compare the clinical outcome of intramedullary transplant of olfactory ensheathing cells for patients with spinal cord injury at multi-centers worldwide, and to explore the potential standardized transplantation that suits for the clinical requirements.

Methods:

Here, we used the Pubmed and CNKI databases to search online the literatures published in the last 20 years for the clinical studies/trials of OECs for chronic spinal cord injury in the representative clinical center. The results of these representative clinical treatment centers were searched and analyzed. The parameters which may affect the effect including the concentration of cells, the total number of cells, the choice of incision, the site of transplantation, the number of transplantation sites, the advantages and disadvantages of transplantation equipment, and postoperative management, were compared carefully to clarify its impact on the clinical results.

Results:

In these literatures, 2 Chinese centers, 1 Australian center and 1 European center were selected for intraspinal transplantation. The reason of different results may be due to the excessive injection times and/or the excessive total injection volume.

Conclusions:

Cell implant to the spinal cord parenchyma is effective for restoring neurological functions, but improper procedures may lead to ineffective results. Concise surgery appears to be more suitable for clinical application than ostensibly precise and complex injection procedures. Sufficient rehabilitation training is surely necessary for the integration of motor recovery after cell transplantation.

References

[1]
Gomes ED, Mendes SS, Assunção-Silva RC, et al. Cotransplantation of adipose tissue-derived stromal cells and olfactory ensheathing cells for spinal cord injury repair. Stem Cells. 2018, 36(5): 696-708.
[2]
Gómez RM, Sánchez MY, Portela-Lomba M, et al. Cell therapy for spinal cord injury with olfactory ensheathing glia cells (OECs). Glia. 2018, 66(7): 1267-1301.
[3]
Ramon-Cueto A, Nieto-Sampedro M. Regeneration into the spinal cord of transected dorsal root axons is promoted by ensheathing glia transplants. Exp Neurol 1994, 127(2): 232-244
[4]
Li Y, Field PM, Raisman G. Repair of adµlt rat corticospinal tract by transplants of olfactory ensheathing cells. Science. 1997, 277(5334): 2000-2002.
[5]
Huang H, Chen L, Xi H, et al. Olfactory ensheathing cells transplantation for central nervous system diseases in 1255 patients. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2009, 23(1): 14-20.
[6]
Huang H, Chen L, Wang H, et al. Safety of fetal olfactory ensheathing cell transplantation in patients with chronic spinal cord injury. A 38-month follow-up with MRI. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2006, 20(4): 439-443.
[7]
Huang H, Chen L, Wang H, et al. Influence of patients’ age on functional recovery after transplantation of olfactory ensheathing cells into injured spinal cord injury. Chin Med J (Engl). 2003, 116(10): 1488-1491.
[8]
Nategh M, Firouzi M, Naji-Tehrani M, et al. Subarachnoid space transplantation of Schwann and/or olfactory ensheathing cells following severe spinal cord injury fails to improve locomotor recovery in rats. Acta Med Iran. 2016, 54(9): 562-569.
[9]
Huang HY, Chen L, Zou QY, et al. Clinical cell therapy guidelines for neurorestoration (China version 2016). J Neurorestoratology. 2017: 539-546.
[10]
Huang H, Xi H, Chen L, et al. Long-term outcome of olfactory ensheathing cell therapy for patients with complete chronic spinal cord injury. Cell Transplant. 2012, 21(S1): S23-S31.
[11]
Wang D, He X, Li H, et al. Long-term efficiency of P75- positive olfactory ensheathing cell transplantation in 24 patients with spinal cord injury. Chin J Cell Stem Cell (Electronic Edition) 2012, 2(3): 185-190.
[12]
Zheng ZC, Wei KB, Liu F, et al. Clinical verification of olfactory ensheathing cell transplantation in treatment of spinal cord injury. Zhongguo Zuzhi Gongcheng Yanjiu yu LinchuangKangfu. 2010, 14(27): 5119-5122.
[13]
Rao Y, Zhu W, Liu H, et al. Clinical application of olfactory ensheathing cells in the treatment of spinal cord injury. J Int Med Res. 2013, 41(2): 473-481.
[14]
Tabakow P, Jarmundowicz W, Czapiga B, et al. Transplantation of autologous olfactory ensheathing cells in complete human spinal cord injury. Cell Transplant. 2013, 22(9): 1591-1612.
[15]
Mackay-Sim A, Féron F, Cochrane J, et al. Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial. Brain. 2008, 131(Pt 9): 2376-2386.
[16]
Féron F, Perry C, Cochrane J, et al. Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain. 2005, 128(Pt 12): 2951-2960.
[17]
Huang H, Wang H, Chen L, et al. Influence Factors for functional improvement after olfactory ensheathing cell transplantation for chronic spinal cord injury. Chinese Journal of Reparative and Reconstructive Surgery 2006, 20: 434-438.
[18]
Huang H, Chen L, Sanberg P. Cell therapy from bench to bedside translation in CNS neurorestoratology era. Cell Med. 2010, 1(1): 15-46.
[19]
Guest J, Benavides F, Padgett K, et al. Technical aspects of spinal cord injections for cell transplantation. Clinical and translational considerations. Brain Res Bull. 2011, 84(4–5): 267-279.
[20]
Jiang X, Xiao J, Ren Y, et al. The influence of 4 degree centigrade concervation on cells activity of rats’ olfactory bulbs derived olfactory ensheathing cells. Progress of Anatomical Sciences. 2011, 17(5): 424-427.
Journal of Neurorestoratology
Pages 146-151
Cite this article:
Chen L, Zhang Y, He X, et al. Comparison of intramedullary transplantation of olfactory ensheathing cell for patients with chronic complete spinal cord injury worldwide. Journal of Neurorestoratology, 2018, 6(1): 146-151. https://doi.org/10.26599/JNR.2018.9040012

443

Views

7

Downloads

9

Crossref

9

Web of Science

0

Scopus

Altmetrics

Received: 06 December 2018
Accepted: 17 December 2018
Published: 30 December 2018
© The author(s) 2018

© The authors 2018. This article is published with open access at http://jnr.tsinghuajournals.com

Return